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ABSTRACT
A novel multifunctional controlled pore glass, MF-CPG (Fig. 1), has been synthesized and used
to incorporate 3' terminal primary aliphatic amines into synthetic oligonucleotides. MF-CPG consists
of a unique succinic acid linking arm which possesses both a masked primary amine for label attachment
and a dimethoxytrityl protected hydroxyl for nucleotide chain elongation. Using MF-CPG, we have
devised a simple and convenient technique to attach non-radioactive labels to the 3' terminus of
oligonucleotides. Bifunctional probes can then be constructed by 32p labeling the 5' terminus with
T4 kinase and gamma 32P-ATP. Using such bifunctional oligonucleotide probes in conjunction with
polymerase chain reaction (PCR) amplification, we were able to detect single base substitutions in
a target segment of the human H-ras protooncogene employing either functionality. Our technique
thus expands the potential applications for oligonucleotides as hybridization probes.
INTRODUCTION
Methods to covalently attach labels and reporter molecules to oligonucleotides have
permitted their use as non-radioactive hybridization probes. New technologies in non-
isotopic gene probes'-9, DNA sequencing analysis'0-13, electron microscopy'4, and X-
ray crystallographyl2 have provided impetus for the development and improvement of
such methods. As applications continue to emerge, more convenient oligonucleotide labeling
techniques and reagents will be required.
Current methods to introduce chemical modifications into oligonucleotides employ special
phosphoramidite reagents during solid phase synthesis. Attention has focused on the 5'
terminus and a number of protected amino-alkyl phosphoramidites have been
reported2 -4,10,lll14,l5 to incorporate a 5' terminal aliphatic primary amine.
Oligonucleotides modified by these reagents can be subsequently derivatized with
fluorophores, biotin, and other molecules. Similarly, phosphoramidite reagents have also
been described which incorporate a thiol functionality on the 5' terminus'2"3"6.
Techniques modifying the 3' terminus are inconvenient and tedious. Lemaitre et al'7"18
have described the attachment of a ribonucleoside to the 3' terminus of an oligonucleotide
using T4 RNA ligase. Terminal 3' modification was achieved after periodate-oxidation
of the ribose ring followed by reductive amination. Another procedure by Zuckermann
et al'9 incorporates a 3' terminal thiol group via solid phase oligonucleotide synthesis.
Although this procedure is more efficient, it requires many synthetic steps and purifications.
Herein we report the synthesis and use of a novel multifunctional controlled pore glass,
MF-CPG (Fig. 1), which introduces an aliphatic primary amine to the 3' terminus of an
oligonucleotide via solid phase synthesis. MF-CPG consists of a unique succinic acid linking
arm which possesses both a masked primary amine for label attachment and a
7187











2. AC O, DMAP, pyr
0 OAc OMe
0 NH O
DMT-0 ~NilN(, .~ -ltT-O / b N~~ ~ ~ ~~~~t1
FmocNl 0 0 OMe
MF-CPG
Figure 1. Synthetic Scheme for MF-CPG
dimethoxytrityl protected hydroxyl for nucleotide chain elongation. Any oligonucleotide
sequence can be synthesized on MF-CPG using conventional cyanoethyl phosphoramidite
protocols in automated DNA synthesizers. After the usual ammonium hydroxide treatment
for cleavage and deprotection, the 3' amino-modified oligonucleotide is obtained. The
method is efficient and convenient, requiring no extra steps or reagents other than those
used for normal oligonucleotide synthesis.
Using this MF-CPG based synthesis, we have constructed oligonucleotide probes which
can be biotinylated at the 3' terminus, and 32P radiolabeled at the 5' terminus. These
bifunctional probes were able to distinguish a single base pair substitution in a target segment
of the H-ras protooncogene using either a streptavidin-alkaline phosphatase detection system
or autoradiography.
MATERIALS AND METHODS
Long chain alkylamine CPG was purchased from Pierce Chemical Co. Biotin-XX-NHS
ester, PCR amplimers, and the Gene-tect Non-Isotopic Detection System were obtained
from Clontech Laboratories, Inc. Taq polymerase was acquired from Perkin Elmer Cetus.
HPLC was performed on a Rainin Rabbit HPX System using aquapore C8 reverse phase
columns (Applied Biosystems, Inc.) for both preparative (100 x 10 mm) and analytical
(30 x4.6 mm) runs. A Biosearch Cyclone DNA synthesizer was used for oligonucleotide
synthesis.
Preparation of MF-CPG
To a solution of N-Fmoc-O-DMT-3-amino-1,2-propanediol2I (2.2 g, 3.5 mmol) and
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Figure 2. HPLC Chromatograms of Purified 3' Biotinylated H-ras Oligonucleotide Probes. A RP-C8 analytical
column was used with the following gradient system: A=0.1 M triethylammonium acetate (pH 7), B=40%
acetonitrile in 0.1 M triethylammonium acetate; 12.5-35% B, 25 min, hold at 35% B. A: H-ras codon 13 wild
type probe; B: H-ras codon 13 probe containing Asp mutation.
succinic anhydride (300 mg, 3 mmol). The reaction was stirred at room temperature for
17 hrs. The consumption of starting material was followed by TLC using methanol-
dichloromethane (1:49) as the mobile phase. The mixture was diluted in ethyl acetate (100
ml), washed with 0.5 M sodium chloride (3 x 100 ml) and saturated sodium chloride (1 x
100 ml), and dried over anh. sodium sulfate. After concentrating by rotary evaporation
and drying under high vacuum (45°C), 1.74 g of a yellow solid was obtained.
The yellow solid was dissolved in dry dioxane (10 ml) containing anh. pyridine (0.5
ml) and p-nitrophenol (350 mg, 2.5 mmol). Dicyclohexylcarbodiimide (1.0 g, 4.8 mmol)
was added and the mixture was stirred at ambient temperature. After a few minutes,
7189
Nucleic Acids Research
dicyclohexylurea began to precipitate. The reaction was monitored by TLC (methanol-
dichloromethane, 1:9) and after 3 hrs the dicyclohexylurea was collected by filtration.
Long chain alkylamine CPG (5.0 g) was suspended in the filtrate containing the p-
nitrophenyl ester derivative, triethylamine (1.0 ml) was added, and the mixture was shaken
overnight at room temperature. The derivatized support was copiously washed with
dimethylformamide, methanol, and diethyl ether and dried in vacuo. Before capping the
unreacted alkylamine groups, the loading capacity of the MF-CPG was assayed by
determining the amount of dimethoxytrityl cation released upon treatment with perchloric
acid according to published procedures22.
Finally, capping of MF-CPG was achieved by treatment with acetic anhydride-pyridine-
DMAP (10:90:1, v/v/w) for 1 hr. The support was thoroughly washed with methanol and
diethyl ether and dried under high vacuum to give 4.95 g of MF-CPG. The capped MF-
CPG gave a negative ninhydrin test10.
Synthesis of 3' Biotinylated Oligonucleotide Probes
Two 3' amino-modified oligonucleotides, GGCGCCGGCGGTGTGGGCAA-X (H-ras,
wild type) and GGCGCCGGCGATGTGGGCAA-X (H-ras, codon 13 Asp) [X = 3'
primary amine modification], were synthesized using MP-CPG on a Biosearch Cyclone
DNA synthesizer. Standard columns were packed with 1 Amol of MF-CPG and DNA
synthesis was performed by suggested manufacturer protocols without any program changes.
The coupling efficiency of the first nucleotide was determined by measuring the deprotected
dimethoxytrityl cation concentration. Solid support cleavage and deprotection was
accomplished with concentrated ammonium hydroxide.
Each crude amino-modified oligonucleotide was dissolved in 0.8 ml of 0. 1 M
NaHCO3/NaCO3 (pH 9). Biotin-XX-NHS ester in dimethylformamide (100 mg/ml, 0.25
ml) was added and the mixture was allowed to react for 16 hrs at room temperature. The
biotinylated probes were purified on Sephadex G-25 columns (1 x40 cm) and then by
preparative HPLC. Analytical HPLC chromatograms of the purified 3' biotinylated probes
are shown in Figure 2. The presence of biotin was confirmed by a p-
methylaminocinnamaldehyde colorimetric test23.
32p 5' End Labeling of the Biotinylated Oligonucleotide Probes
The H-ras biotinylated probes were 32P 5' end labeled using a modification of the method
described by Berent et a124. 100 ng of the oligonucleotide probe were dissolved in 30 /O
of distilled water and heated to 65°C for 3 minutes. The oligomers were then taken up
to 50 ,ul of a reaction buffer which contained 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2,
5 /LM DTT, 0.1 mM spermidine, 10 pd gamma 32P-ATP (specific activity 6000 Ci/mM),
and 15-20 units of T4 kinase. This reaction mixture was incubated at 37°C for 30 minutes
followed by the addition of another 15-30 units of kinase and further incubation for 30
minutes. The labeled probe was then isolated using a G-25 Sephadex column.
PCR Amplification of the H-ras Protooncogenes
Amplification of genomic DNA by the polymerase chain reaction (PCR) has been previously
described' 20. Two different sets of amplifying primers (amplimers) were used to amplify
specific ras oncogene segments of genomic DNA. ATGACGGAATATAAGCTGGT
(5' H-ras amplimer) and CTCTATAGTGGGGTCGTATT (3' H-ras amplimer) were
used to amplify the region around codons 12 and 13 of the H-ras gene;
ATGACTGAGTACAAACTGGT (5' N-ras amplimer) and CTCTATGGTGGGATCATATT
(3' N-ras amplimer) were used to amplify the same codon region of the N-ras gene. 1
,tg of genomic DNA was amplified in a 100 pA volume containing 50 mM KCI, 10 mM
7190
Nucleic Acids Research
Tris (pH 8.3), 1.5 mM MgCl2, 0.1% gelatin, 0.5 mM all four dNTPs, and 2.5 units Taq
polymerase. The first amplification cycle included denaturation at 95°C for 5 min, annealing
at 55°C for 2 min, and primer extension at 68°C for 2 minutes. The remaining 35 cycles
were performed with 2 minute incubation periods at each temperature.
The generation of target DNA with a H-ras codon 13 Asp mutation was accomplished
by the method described by Rochlitz et aF25. In this reaction, the sequence of the 3'
amplifying oligomer has been noted above. The 5' amplimer, however, encompasses the
20 nucleotide sequence at codon 12 and 13 of H-ras and contains a point mutation encoding
a glycine to aspartate change in codon 13 (GGCGCCGGCGATGTGGGCAA). DNA
generated through PCR amplification was used as target DNA in oligonucleotide
hybridization analysis. In this manner, the amplified DNA incorporates the oligonucleotide
with the codon 13 aspartate mutation.
Hybridization ofProbe and Post Hybridization Washes with Tetramethylammonium Cloride
(TMAC)
40 t1l of the amplified samples were added to 80 yl of 0.4 N NaOH, and heated to 95°C
for 2 minutes. The reaction mixtures were neutralized with 100 Al of 2 M Tris-HCl(pH
7.4), and the solution slotted onto Amersham Hybond nylon filter. The DNA was
crosslinked onto the filter by UV radiation under conditions suggested by the manufacturer.
The slot blots were pre-hybridized for 2 hours at 37°C with 10-15 mls of 5 x SSPE,
5 x Denhardt's, 0.5% SDS, and 100 mM sodium pyrophosphate (pH 7.5). A labeled probe
was then added to this solution to a final concentration of 5 x 106 cpm/ml and the filters
were hybridized at 50°C for 4 to 12 hours. Following this incubation, the filters were
washed once at room temperature with 6 x SSC for 20 minutes, and twice at 61 °C in
3 M TMAC, 50 mM Tris-HCl (pH 8), 2 mM EDTA, and 0.1 % SDS. The filters were
then washed once at room temperature with 6x SCC. Hybridization was detected both
by autoradiography, and by colorimetric detection with a streptavidin-alkaline phosphatase
conjugate (Clontech's Gene-tect System) on the same slot blot.
RESULTS
The preparation of MF-CPG is outlined in Figure 1. N-Fmoc-O-DMT-
3-amino-1,2-propanediol2' was first derivatized with succinic anhydride. The carboxyl
group of the succinylated derivative was converted to a p-nitrophenyl ester and directly
reacted with long chain alkylamine CPG to give MF-CPG. After capping, the loading
capacity of MF-CPG was determined to be 27.8 ,^mol/g.
We constructed two bifunctional oligonucleotide probes using MF-CPG as follows. First,
two 3' amino-modified oligonucleotides, GGCGCCGGCGGTGTGGGCAA-X (H-ras, wild
type) and GGCGCCGGCGATGTGGGCAA-X (H-ras, codon 13 Asp) [X = 3' primary
amine modification], were synthesized using MP-CPG. The coupling efficiency of the first
nucleotide, which is indicative of 3' primary amine incorporation, was >97% in both
cases. After standard cleavage and deprotection with ammonium hydroxide, the crude 3'
amino-modified oligonucleotides were biotinylated with Biotin-XX-NHS ester. The long
linking arm of Biotin-XX-NHS ester, a 14 atom spacer (XX) consisting of two e-
aminocaproic acid moieties linked in series, was used to make the biotins more available
for detection. After size exclusion on Sephadex G-25, the biotinylated oligonucleotides
were purified by preparative HPLC on a C8 reverse phase column. Analytical HPLC
chromatograms are shown in Fig. 2. The presence of biotin was confirmed by a p-










Figure 3. Detection of point mutations in the human H-ras gene using specific bifunctional oligonucleotide probes.
DNA samples were PCR amplified and analyzed as described in the Materials and Methods. In all panels, slot
1 is DNA amplified around H-ras codon 13 from human placental DNA (GGT, glycine at codon 13), slot 2
is DNA amplified around H-ras codon 13 from mouse 3T3 cells transformed with a human H-ras gene bearing
a glycine to valine mutation in H-ras codon 12 (GTT), slot 3 is human DNA amplified around H-ras codon
13 with a codon 13 aspartate mutation, and slot 4 is human placental DNA amplified around N-ras codons 12
and 13. Panel A: slot blot was hybridized with a 32P-labeled oligonucleotide probe (20mer) specific for the wild
type H-ras 13 sequence (GGT). The signal was detected by autoradiography. Panel B: slot blot was hybridized
with a 32P-labeled oligonucleotide probe (20mer) specific for an aspartate mutation in H-ras codon 13 (GAT).
The signal was detected by autoradiography. Panel C: the same slot blot as in Panel A but the signal was detected
colorimetrically using a streptavidin-alkaline phosphatase conjugate. Panel D: the same slot blot as in panel B
but the signal was detected colorimetrically using a streptavidin-alkaline phosphatase conjugate.
bifunctional probes was completed by 32p labeling of the 5' ends with T4 kinase and
gamma 32P-ATP.
We assessed the applicability of these bifunctional oligonucleotide probes in detecting
single base substitutions in the H-ras protooncogene. The probes used were specific either
for the wild type H-ras sequence at codon 13 (GGT) or for the transforming mutant sequence
at codon 13 (GAT) which substitutes aspartate for glycine. A 110 base pair segment which
includes codon 13 of the H-ras gene was amplified from genomic DNA using the polymerase
(PCR). By autoradiography (Fig. 3B), the codon 13 aspartate probe hybridized only with
the amplified DNA carrying the H-ras codon 13 aspartate mutation and not with DNA
from normal placenta, a transformed mouse fibroblast cell line (NIH-3T3) harboring a
mutant human H-ras gene with a codon 12 valine substitution (GTT), or with placental
DNA amplified in the region surrounding N-ras codons 12 and 13. Hybridization with
the wild type codon 13 H-ras probe (Fig. 3A) however showed a signal only with amplified
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DNA from normal placenta and the NIH3T3 cell line whose murine H-ras gene can also
be amplified using our current amplimers (data not shown). Cross hybridization between
the human and mouse wild type H-ras genes was unexpected but may indicate that the
sequences probed appears are identical in the two species.
When the same filters were incubated with streptavidin-alkaline phosphatase and BCIP,
colorimetric signals were seen over the same slots exhibiting a radiographic signal (Fig.
3C and 3D). Thus when used in conjunction with PCR these bifunctional probes are both
sensitive and specific in detecting single base pair mismatches in target DNA. Furthermore,
an oligonucleotide probe from a single MF-CPG preparation can be either biotinylated
or radiolabeled without compromising hybridization sensitivity.
DISCUSSION
Single base substitutions in human genes are the cause or are strongly associated with a
variety of human diseases such as the hemaglobinopathies20'26 and cancer1 27'28.
Previously, if no convenient restriction sites were altered by the base change, then the
only recourse has been to clone and sequence the affected gene. Recently, PCR amplification
of the DNA segment in question coupled with hybridization of specific oligonucleotide
probes has allowed sequence determination without the need for molecular cloning. The
applicability of the latter technique is dependent on the availability or versatile and
inexpensive oligonucleotide probes. In this report, we have described a novel and simple
method to synthesize 3' labeled oligonucleotides.
In conventional solid phase DNA synthesis, the 3' terminal nucleotide is pre-attached
to the CPG support from the 3' hydroxyl through a succinimic acid linking arm and the
oligonucleotide is synthesized from the 5' hydroxyl by repetitive cycles of chemical
reactions. Therefore, an expedient strategy to introduce a 3' primary aliphatic amine would
be to replace the preattached nucleoside with a unique multifunctional linking arm. Using
this strategy, we have constructed a multifunctional CPG, MF-CPG (Fig. 1) which transfers
a primary amine to the 3' terminus of a synthesized oligonucleotide without changing any
chemistry or adding extra steps. MF-CPG possesses a uniquely engineered linking arm
that complies with four important criteria. First, the linking arm is attached to the CPG
through an ester functionality that is readily cleaved with ammonium hydroxide treatment.
Second, the linking arm contains a masked primary aliphatic amine which is acid stabile
and resistent to all the reagents used in normal oligonucleotide synthesis. Third, in addition
to being acid stable, the amine protecting group is readily removed with ammonium
hydroxide treatment. Fourth, the linking arm contains a dimethoxytrityl protected primary
hydroxyl group for oligonucleotide chain elongation. Hence, the method is fully adaptable
to commercial DNA synthesizers and is as easy as synthesizing normal oligonucleotides.
Since a reporter molecule now can be easily attached to the 3' terminus of any
oligonucleotide, both the 5' and 3' termini can be used to label the oligonucleotide. We
have shown that such bifunctional oligonucleotide probes are both sensitive and specific
in detecting single base substitutions in target DNA when used in conjunction with PCR.
The sensitivity and specificity were the same regardless of the detection system;
autoradiography or colorimetric detection with a streptavidin-alkaline phosphatase conjugate.
The convenience of using MF-CPG to non-isotopically label an oligonucleotide at the 3'
terminus with subsequent 32p labeling at the 5' terminus makes this reagent an attractive
alternative to current methods of functionalizing oligonucleotides. Thus, our technique
expands the potential for applications employing functionalized oligonucleotides.
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